Novavax reports preliminary data from Covid-19-influenza vaccine trial
In Phase I/II trial, the combination vaccine was found to be well-tolerated and immunogenic.
Suvoda WP
Panthera raises funds to expedite expansion of clinical trial sites
AstraZeneca’s Evusheld offers protection against Covid-19 in Phase III trial
Synaptogenix concludes subject enrolment in Phase IIb Alzheimer’s trial
AI benefits in patient identification and clinical trial recruitment has challenges in sight
Amgen’s Phase III trial of ABP 654 meets primary efficacy endpoint
TCS introduces monitoring solution for clinical trials
Thread acquires CureClick to improve trial awareness, access
